Inquiry
Form loading...

High-Quality Nintedanib 656247-17-5 Manufacturers & Supplier Options

Discover Nintedanib 656247-17-5, a powerful pharmaceutical ingredient developed by NINGBO SINOVA I/E CORP, designed to treat a range of pulmonary conditions. This innovative drug has shown promising results in the treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases. Nintedanib 656247-17-5 works by targeting multiple tyrosine kinases involved in the growth and progression of fibrotic tissue in the lungs, ultimately slowing down the disease's advancement and providing much-needed relief for patients

Related products

Top Selling Products

Related Search

Leave Your Message